Kelvin Chan

13.0k total citations · 1 hit paper
378 papers, 7.5k citations indexed

About

Kelvin Chan is a scholar working on Oncology, Economics and Econometrics and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Kelvin Chan has authored 378 papers receiving a total of 7.5k indexed citations (citations by other indexed papers that have themselves been cited), including 173 papers in Oncology, 134 papers in Economics and Econometrics and 85 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Kelvin Chan's work include Health Systems, Economic Evaluations, Quality of Life (113 papers), Economic and Financial Impacts of Cancer (94 papers) and Colorectal Cancer Treatments and Studies (35 papers). Kelvin Chan is often cited by papers focused on Health Systems, Economic Evaluations, Quality of Life (113 papers), Economic and Financial Impacts of Cancer (94 papers) and Colorectal Cancer Treatments and Studies (35 papers). Kelvin Chan collaborates with scholars based in Canada, United States and United Kingdom. Kelvin Chan's co-authors include Lillian L. Siu, Amit M. Oza, Matthew C. Cheung, Nancy Y. Lee, Murray Krahn, Andrew T. Yan, Stuart Peacock, Ronak Saluja, Kelly Lien and Ashwatha Narayana and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Oncology and Blood.

In The Last Decade

Kelvin Chan

352 papers receiving 7.4k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

The statins as anticancer agents.

2003 521 citations Kelvin Chan et al. profile →

Peers

Kelvin Chan

ONCOL

PRM

SURGE

William J. Mackillop Canada

James B. Yu United States

Michael LeBlanc United States

Gemma Gatta Italy

Rajendra Badwe India

Anne‐Michelle Noone United States

Riccardo Capocaccia Italy

Alexia Iasonos United States

Harry Comber Ireland

Martin Krapcho United States

William J. Mackillop Canada

Kelvin Chan

2.8k ×1.0

ONCOL

2.3k ×1.1

PRM

1.8k ×1.2

SURGE

617 ×0.6

1.0k ×1.0

Citations per year, relative to Kelvin Chan Kelvin Chan (= 1×) peers William J. Mackillop

Countries citing papers authored by Kelvin Chan

Since Specialization

Citations

This map shows the geographic impact of Kelvin Chan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kelvin Chan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kelvin Chan more than expected).

Fields of papers citing papers by Kelvin Chan

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kelvin Chan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kelvin Chan. The network helps show where Kelvin Chan may publish in the future.

Co-authorship network of co-authors of Kelvin Chan

This figure shows the co-authorship network connecting the top 25 collaborators of Kelvin Chan. A scholar is included among the top collaborators of Kelvin Chan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kelvin Chan. Kelvin Chan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Eisen, Andrea, et al.. (2024). Comparative Effectiveness and Safety of Trastuzumab Biosimilars to Herceptin for Adjuvant Treatment of HER2+ Breast Cancer. Current Oncology. 31(3). 1633–1644. 2 indexed citations

Erenay, Fatih Safa, et al.. (2024). Cancer Drug Wastage and Mitigation Methods: A Systematic Review. Value in Health. 28(1). 148–160.

Higgins, Kevin, Danny Enepekides, Irene Karam, et al.. (2024). Lymph node yield: Impact on oncologic outcomes in oral cavity cancer. Head & Neck. 46(8). 1965–1974. 3 indexed citations

Chu, William, Amandeep Taggar, Yee Ung, et al.. (2023). Risk-adjusted chemoradiation according to human papilloma viral status for anal cancer: a pilot study. Frontiers in Oncology. 13. 1183854–1183854. 2 indexed citations

Wilson, Brooke E., Annette E. Hay, Kelvin Chan, Matthew C. Cheung, & Timothy P. Hanna. (2023). Augmenting clinical trial economic analysis by linking cancer trial data to administrative data: current landscape and future opportunities. BMJ Open. 13(8). e073353–e073353. 1 indexed citations

Du, Yue, Rui Fu, Kelvin Chan, et al.. (2023). Nivolumab for Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma: A Retrospective Tertiary Centre’s Real-World Experience. Current Oncology. 30(10). 8928–8935. 1 indexed citations

Dai, Wei Fang, Ruth Croxford, Wanrudee Isaranuwatchai, et al.. (2023). Cost‐effectiveness of second‐line ipilimumab for metastatic melanoma: A real‐world population‐based cohort study of resource utilization. Cancer Medicine. 12(10). 11451–11461. 3 indexed citations

Seow, Hsien, et al.. (2022). Trends in quality indicators of end-of-life care for women with gynecologic malignancies in Ontario, Canada. Gynecologic Oncology. 167(2). 247–255. 4 indexed citations

Seow, Hsien, et al.. (2022). Quality of End-of-Life Care in Gastrointestinal Cancers: A 13-Year Population-Based Retrospective Analysis in Ontario, Canada. Current Oncology. 29(12). 9163–9171.

10.

Mason, Warren, et al.. (2022). Clinical features of glioma patients who develop pneumocystis pneumonia with temozolomide chemoradiotherapy. Journal of Neuro-Oncology. 159(3). 665–674. 2 indexed citations

11.

Fu, Rui, Rinku Sutradhar, Qing Li, et al.. (2022). Imaging and physician visits at cancer diagnosis: COVID ‐19 pandemic impact on cancer care. Cancer Medicine. 12(5). 6056–6067. 4 indexed citations

12.

Pataky, Reka, Jaclyn Beca, David Tran, et al.. (2021). Real-World Cost-Effectiveness of Bevacizumab With First-Line Combination Chemotherapy in Patients With Metastatic Colorectal Cancer: Population-Based Retrospective Cohort Studies in Three Canadian Provinces. MDM Policy & Practice. 6(1). 9 indexed citations

13.

Thavorn, Kednapa, Ian D. Graham, Harold Atkins, et al.. (2021). Stakeholder engagement in economic evaluation: Protocol for using the nominal group technique to elicit patient, healthcare provider, and health system stakeholder input in the development of an early economic evaluation model of chimeric antigen receptor T-cell therapy. BMJ Open. 11(8). e046707–e046707. 5 indexed citations

14.

Ezeife, Doreen A., François Dionne, Aline Fusco Fares, et al.. (2019). Value assessment of oncology drugs using a weighted criterion‐based approach. Cancer. 126(7). 1530–1540. 10 indexed citations

15.

Ong, Géraldine, Christine Brezden‐Masley, Djeven P. Deva, et al.. (2018). Myocardial strain imaging by cardiac magnetic resonance for detection of subclinical myocardial dysfunction in breast cancer patients receiving trastuzumab and chemotherapy. International Journal of Cardiology. 261. 228–233. 56 indexed citations

16.

Thein, Hla‐Hla, Nathaniel Jembere, Kednapa Thavorn, et al.. (2018). Estimates and predictors of health care costs of esophageal adenocarcinoma: a population-based cohort study. BMC Cancer. 18(1). 694–694. 16 indexed citations

17.

Truong, Judy, et al.. (2017). The impact of cancer drug wastage on economic evaluations. Cancer. 123(18). 3583–3590. 10 indexed citations

18.

Thein, Hla‐Hla, Yao Qiao, Ahmad Zaheen, et al.. (2017). Cost-effectiveness analysis of treatment with non-curative or palliative intent for hepatocellular carcinoma in the real-world setting. PLoS ONE. 12(10). e0185198–e0185198. 21 indexed citations

19.

Hui, Angela Bik‐Yu, Alice Lin, Wei Xu, et al.. (2013). Potentially Prognostic miRNAs in HPV-Associated Oropharyngeal Carcinoma. Clinical Cancer Research. 19(8). 2154–2162. 88 indexed citations

20.

Haskew-Layton, Renee, N. A. Smirnova, C. Thong, et al.. (2010). Controlled enzymatic production of astrocytic hydrogen peroxide protects neurons from oxidative stress via an Nrf2-independent pathway. Proceedings of the National Academy of Sciences. 107(40). 17385–17390. 127 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact